Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases

BACKGROUND: Metastasis is the leading cause of mortality in malignant diseases. Patients with metastasis often show reduced Lysophosphatidylcholine (LysoPC) plasma levels and treatment of metastatic tumour cells with saturated LysoPC species reduced their metastatic potential in vivo in mouse experi...

Descripción completa

Detalles Bibliográficos
Autores principales: Raynor, Anna, Jantscheff, Peter, Ross, Thomas, Schlesinger, Martin, Wilde, Maurice, Haasis, Sina, Dreckmann, Tim, Bendas, Gerd, Massing, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499168/
https://www.ncbi.nlm.nih.gov/pubmed/26162894
http://dx.doi.org/10.1186/s12944-015-0070-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499168/
https://www.ncbi.nlm.nih.gov/pubmed/26162894
http://dx.doi.org/10.1186/s12944-015-0070-x

Ejemplares similares